Patents Assigned to NEUMEDICINES INC.
  • IL-12 FOR RADIATION PROTECTION AND RADIATION-INDUCED TOXICITY MITIGATION
    Publication number: 20130243722
    Abstract: Aspects and embodiments of the instant disclosure provide therapeutic methods and compositions comprising interleukin 12 (IL-12) useful for treating radiation-induced damage in a subject. In particular, the instant disclosure provides methods and compositions for radiation protection and/or radiation toxicity mitigation for the treatment of acute radiation syndrome and radiation induced toxicity associated with the treatment of cutaneous T-cell lymphoma.
    Type: Application
    Filed: January 18, 2013
    Publication date: September 19, 2013
    Applicant: NEUMEDICINES INC.
    Inventors: Lena Basile, Timothy K. Gallaher, Dolph D. Ellefson